Tight development timelines and accelerated approval pathways favor simple, cost-effective capsule formulations. Capsules are a common oral solid dosage form and are produced in a variety of shapes, ...

Advancements in soft capsule technology can enable the development of soft capsule formulations, which are becoming the preferred method of oral administration. Soft capsule formulation technology ...

Nano-capsules that can modulate the release of the incorporated substances may have applications in the formulation of functional foods, as well as relevance in food preservation and storage, ...

Cyclosporine has revolutionised the transplantation scene in the last 20 years by helping with immunosuppresion. Novartis have so far had the patent Cyclosporine has revolutionised the transplantation ...

Introduction: Different oral sustained-release (SR) formulations of tramadol have been introduced in pain treatment in order to prolong the dosage interval to improve convenience for the patient. The ...

A phase I study of ombrabulin (O) combined with bevacizumab (B) in patients with advanced solid tumors (NCT01193595). A phase I study of R04929097, an oral gamma secretase inhibitor, in combination ...

Phase I study of imetelstat (GRN163L) in combination with paclitaxel (P) and bevacizumab (B) in patients (pts) with locally recurrent or metastatic breast cancer (MBC). Methods: In this randomized, ...

Please provide your email address to receive an email when new articles are posted on . The FDA has given final approval to Perrigo Co.’s miniature 20 mg delayed-release omeprazole magnesium capsules ...

Is there any benefit to using venlafaxine extended-release, 75 mg twice daily, vs venlafaxine extended-release, 150 mg once daily? Would the drug level, once at steady state, be higher given the daily ...

The Company has not disclosed a reason for the medication discontinuation, however in 2017, the FDA reported that olaparib capsules were being phased out of the US market. [UPDATE 9/6/18] Lynparza ...